98 related articles for article (PubMed ID: 15145525)
1. CD9 expression is not a prognostic factor in human osteosarcoma.
Kubista B; Erovic BM; Klinger H; Sulzbacher I; Trieb K
Cancer Lett; 2004 Jun; 209(1):105-10. PubMed ID: 15145525
[TBL] [Abstract][Full Text] [Related]
2. Motility-related protein (MRP-1/CD9) and KAI1/CD82 expression inversely correlate with lymph node metastasis in oesophageal squamous cell carcinoma.
Uchida S; Shimada Y; Watanabe G; Li ZG; Hong T; Miyake M; Imamura M
Br J Cancer; 1999 Mar; 79(7-8):1168-73. PubMed ID: 10098753
[TBL] [Abstract][Full Text] [Related]
3. Motility-related protein-1 (MRP-1/CD9) reduction as a factor of poor prognosis in breast cancer.
Miyake M; Nakano K; Itoi SI; Koh T; Taki T
Cancer Res; 1996 Mar; 56(6):1244-9. PubMed ID: 8640807
[TBL] [Abstract][Full Text] [Related]
4. Reduced motility related protein-1 (MRP-1/CD9) gene expression as a factor of poor prognosis in non-small cell lung cancer.
Higashiyama M; Taki T; Ieki Y; Adachi M; Huang CL; Koh T; Kodama K; Doi O; Miyake M
Cancer Res; 1995 Dec; 55(24):6040-4. PubMed ID: 8521390
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of CD9 expression in locally advanced gastric cancer treated with surgery and adjuvant chemoradiotherapy.
Soyuer S; Soyuer I; Unal D; Ucar K; Yildiz OG; Orhan O
Pathol Res Pract; 2010 Sep; 206(9):607-10. PubMed ID: 20547009
[TBL] [Abstract][Full Text] [Related]
6. Motility related protein 1 (MRP1/CD9) expression in colon cancer.
Mori M; Mimori K; Shiraishi T; Haraguchi M; Ueo H; Barnard GF; Akiyoshi T
Clin Cancer Res; 1998 Jun; 4(6):1507-10. PubMed ID: 9626469
[TBL] [Abstract][Full Text] [Related]
7. KAI-1 expression in pediatric high-grade osteosarcoma.
Leavey PJ; Timmons C; Frawley W; Lombardi D; Ashfaq R
Pediatr Dev Pathol; 2006; 9(3):219-24. PubMed ID: 16944980
[TBL] [Abstract][Full Text] [Related]
8. Increased expression of membrane-type matrix metalloproteinase-1 is correlated with poor prognosis in patients with osteosarcoma.
Uchibori M; Nishida Y; Nagasaka T; Yamada Y; Nakanishi K; Ishiguro N
Int J Oncol; 2006 Jan; 28(1):33-42. PubMed ID: 16327977
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of immunohistochemical expression of ezrin in non-metastatic high-grade osteosarcoma.
Ferrari S; Zanella L; Alberghini M; Palmerini E; Staals E; Bacchini P
Pediatr Blood Cancer; 2008 Apr; 50(4):752-6. PubMed ID: 17886294
[TBL] [Abstract][Full Text] [Related]
10. Down-regulation of CD9 in human ovarian carcinoma cell might contribute to peritoneal dissemination: morphologic alteration and reduced expression of beta1 integrin subsets.
Furuya M; Kato H; Nishimura N; Ishiwata I; Ikeda H; Ito R; Yoshiki T; Ishikura H
Cancer Res; 2005 Apr; 65(7):2617-25. PubMed ID: 15805258
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of TP53 tumor suppressor gene expression and mutations in human osteosarcoma: a meta-analysis.
Pakos EE; Kyzas PA; Ioannidis JP
Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6208-14. PubMed ID: 15448009
[TBL] [Abstract][Full Text] [Related]
12. P-glycoprotein expression in high grade central osteosarcoma and normal bone cells. An immunohistochemical study.
Pösl M; Amling M; Grahl K; Hentz M; Ritzel H; Werner M; Winkler K; Delling G
Gen Diagn Pathol; 1997 Jun; 142(5-6):317-25. PubMed ID: 9228255
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic silencing of the tetraspanin CD9 during disease progression in multiple myeloma cells and correlation with survival.
De Bruyne E; Bos TJ; Asosingh K; Vande Broek I; Menu E; Van Valckenborgh E; Atadja P; Coiteux V; Leleu X; Thielemans K; Van Camp B; Vanderkerken K; Van Riet I
Clin Cancer Res; 2008 May; 14(10):2918-26. PubMed ID: 18483358
[TBL] [Abstract][Full Text] [Related]
14. The association of P-glycoprotein with response to chemotherapy and clinical outcome in patients with osteosarcoma. A meta-analysis.
Pakos EE; Ioannidis JP
Cancer; 2003 Aug; 98(3):581-9. PubMed ID: 12879476
[TBL] [Abstract][Full Text] [Related]
15. VEGF expression as a prognostic marker in osteosarcoma.
Bajpai J; Sharma M; Sreenivas V; Kumar R; Gamnagatti S; Khan SA; Rastogi S; Malhotra A; Bakhshi S
Pediatr Blood Cancer; 2009 Dec; 53(6):1035-9. PubMed ID: 19621435
[TBL] [Abstract][Full Text] [Related]
16. Expression of matrix metalloproteinase regulator, RECK, and its clinical significance in osteosarcoma.
Xu J; Wu S; Shi X
J Orthop Res; 2010 Dec; 28(12):1621-5. PubMed ID: 20973064
[TBL] [Abstract][Full Text] [Related]
17. TGF-beta receptor 2 downregulation in tumour-associated stroma worsens prognosis and high-grade tumours show more tumour-associated macrophages and lower TGF-beta1 expression in colon carcinoma: a retrospective study.
Bacman D; Merkel S; Croner R; Papadopoulos T; Brueckl W; Dimmler A
BMC Cancer; 2007 Aug; 7():156. PubMed ID: 17692120
[TBL] [Abstract][Full Text] [Related]
18. MRP-1/CD9 gene transduction downregulates Wnt signal pathways.
Huang CL; Liu D; Masuya D; Kameyama K; Nakashima T; Yokomise H; Ueno M; Miyake M
Oncogene; 2004 Sep; 23(45):7475-83. PubMed ID: 15334057
[TBL] [Abstract][Full Text] [Related]
19. Expression of CUB domain containing protein (CDCP1) is correlated with prognosis and survival of patients with adenocarcinoma of lung.
Ikeda J; Oda T; Inoue M; Uekita T; Sakai R; Okumura M; Aozasa K; Morii E
Cancer Sci; 2009 Mar; 100(3):429-33. PubMed ID: 19077003
[TBL] [Abstract][Full Text] [Related]
20. Epidermal growth factor receptor expression in high-grade osteosarcomas is associated with a good clinical outcome.
Kersting C; Gebert C; Agelopoulos K; Schmidt H; van Diest PJ; Juergens H; Winkelmann W; Kevric M; Gosheger G; Brandt B; Bielack S; Buerger H
Clin Cancer Res; 2007 May; 13(10):2998-3005. PubMed ID: 17505002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
